Claims for Patent: 5,854,051

Summary for Patent: 5,854,051

Title:	Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof
Abstract:	The present invention relates to: parasitic helminth asparaginase proteins; parasitic helminth asparaginase nucleic acid molecules, including those that encode such asparaginase proteins; antibodies raised against such asparaginase proteins; and compounds that inhibit parasitic helminth asparaginase activity. The present invention also includes methods to obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to protect animals from diseases caused by parasitic helminths.
Inventor(s):	Chandrashekar; Ramaswamy (Fort Collins, CO), Tsuji; Naotoshi (Fort Collins, CO)
Assignee:	Heska Corporation (Fort Collins, CO) Colorado State University Research Foundation (Fort Collins, CO)
Application Number:	08/929,501
Patent Claims:	1. An isolated nucleic acid molecule comprising a nucleic acid sequence encoding a Dirofilaria immitis asparaginase protein, or its complementary sequence. 2. The nucleic acid molecule of claim 1, wherein said nucleic acid molecule comprises a nucleic acid sequence selected from the group consisting of nDiASNase.sub.1753 (SEQ ID NO:1 and its complementary sequence), nDiASNase.sub.1518 (SEQ ID NO:4 and its complementary sequence), nDiASNase.sub.439 (SEQ ID NO:6 and its complementary sequence), nDiASNase.sub.369 (SEQ ID NO:9 and its complementary sequence), nDiASNase.sub.1770 (SEQ ID NO:11 and its complementary sequence) and nDiASNase.sub.2073 (SEQ ID NO:25 and its complementary sequence). 3. The nucleic acid molecule of claim 1, wherein said nucleic acid molecule comprises a nucleic acid sequence selected from the group consisting of: a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:25 and SEQ ID NO:26; and an allelic variant thereof. 4. The nucleic acid molecule of claim 1, wherein said nucleic acid molecule encodes a protein having an amino acid sequence selected from the group consisting of SEQ ID NO:2 and SEQ ID NO:12. 5. The nucleic acid molecule of claim 1, wherein said nucleic acid molecule comprises at least about 15 contiguous nucleotides of a nucleic acid molecule having a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:25 and SEQ ID NO:26. 6. A recombinant molecule comprising a nucleic acid molecule as set forth in claim 1 operatively linked to a transcription control sequence. 7. A recombinant virus comprising a nucleic acid molecule as set forth in claim 1. 8. A recombinant cell comprising a nucleic acid molecule as set forth in claim 1. 9. A method to produce a Dirofilaria immitis asparaginase protein comprising culturing in an effective medium a recombinant cell as

Details for Patent 5,854,051

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2039-03-29